Select Publications

Journal articles

Tsugawa J; Noto Y-I; Dharmadasa T; Garg N; Kiernan MC, 2018, '4. Median/ulnar nerve ultrasound cross-sectional area ratio in ALS', Clinical Neurophysiology, 129, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2017.12.017

Timmins HC; Li T; Grimison P; Murray JE; Cox KM; Horvath LG; Lewis CR; Goldstein D; Kiernan MC; Park SB, 2018, '5. Neurophysiological dysfunction in chemotherapy-treated patients: Comparison of different platinum analogues', Clinical Neurophysiology, 129, pp. e2 - e3, http://dx.doi.org/10.1016/j.clinph.2017.12.018

van den Bos MAJ; Menon P; Geevasinga N; Kiernan MC; Vucic S, 2018, '6. ALS disability is predicted by a shift in the balance between short latency facilitatory and inhibitory circuits', Clinical Neurophysiology, 129, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2017.12.019

Walker S; Narasimhan M; Matamala JM; Dharmadasa T; Kiernan MC; Huynh W, 2018, '7. Papillary thyroid cancer in a patient with Morvan’s syndrome', Clinical Neurophysiology, 129, pp. e3 - e4, http://dx.doi.org/10.1016/j.clinph.2017.12.020

Li T; Howells J; Lin CSY; Garg N; Kiernan MC; Park SB, 2018, '8. Predicting motor disorders from nerve excitability studies', Clinical Neurophysiology, 129, pp. e4 - e4, http://dx.doi.org/10.1016/j.clinph.2017.12.021

Agarwal S; Highton-Williamson E; Matamala JM; Caga J; Howells J; Vucic S; Ahmed RM; Kiernan MC, 2018, '9. Upper motor neuron dysfunction and neuropsychological profile in PLS: Another entrant on the ALS-FTD spectrum', Clinical Neurophysiology, 129, pp. e4 - e4, http://dx.doi.org/10.1016/j.clinph.2017.12.022

Doneza J; Windmiller S; Kiernan M; Brodman M; Mathews S; Ascher-Walsh C, 2018, '97: Correlation of self-reported surgical volume with performance of procedural tasks on the laparoscopic simulator', American Journal of Obstetrics and Gynecology, 218, pp. S951 - S951, http://dx.doi.org/10.1016/j.ajog.2017.12.116

Matamala JM; Howells J; Dharmadasa T; Trinh T; Ma Y; Vucic S; Burke D; Kiernan M, 2018, 'F147. Absolute and relative reliability of short-interval intracortical inhibition measured by threshold tracking transcranial magnetic stimulation', Clinical Neurophysiology, 129, pp. e122 - e123, http://dx.doi.org/10.1016/j.clinph.2018.04.310

Dharmadasa T; Matamala JM; Howells J; Vucic S; Kiernan M, 2018, 'S151. Assessing lower limb cortical function with threshold tracking transcranial magnetic stimulation', Clinical Neurophysiology, 129, pp. e198 - e198, http://dx.doi.org/10.1016/j.clinph.2018.04.511

Noto Y-I; Simon NG; Selby A; Garg N; Vucic S; Kiernan M, 2018, 'T41. Ectopic impulse generation in peripheral nerve hyperexcitability syndromes and amyotrophic lateral sclerosis', Clinical Neurophysiology, 129, pp. e17 - e17, http://dx.doi.org/10.1016/j.clinph.2018.04.042

Geevasinga N; Korgaonkar MS; Menon P; Van den Bos M; Gomes L; Foster S; Kiernan MC; Vucic S, 2017, 'Brain functional connectome abnormalities in amyotrophic lateral sclerosis are associated with disability and cortical hyperexcitability', European Journal of Neurology, 24, pp. 1507 - 1517, http://dx.doi.org/10.1111/ene.13461

Noto YI; Shibuya K; Shahrizaila N; Huynh W; Matamala JM; Dharmadasa T; Kiernan MC, 2017, 'Detection of fasciculations in amyotrophic lateral sclerosis: The optimal ultrasound scan time', Muscle and Nerve, 56, pp. 1068 - 1071, http://dx.doi.org/10.1002/mus.25607

Turner MR; Al-Chalabi A; Chio A; Hardiman O; Kiernan MC; Rohrer JD; Rowe J; Seeley W; Talbot K, 2017, 'Genetic screening in sporadic ALS and FTD', Journal of Neurology, Neurosurgery and Psychiatry, 88, pp. 1042 - 1044, http://dx.doi.org/10.1136/jnnp-2017-315995

Moalem-Taylor G; Baharuddin B; Bennett B; Krishnan AV; Huynh W; Kiernan MC; Shin-Yi Lin C; Shulruf B; Keoshkerian E; Cameron B; Lloyd A; Lin C, 2017, 'Immune dysregulation in patients with carpal tunnel syndrome', Scientific Reports, 7, pp. 8218, http://dx.doi.org/10.1038/s41598-017-08123-6

Caldwell C; Kiernan M, 2017, 'The longest sleep', The Lancet Neurology, 16, pp. 961 - 962, http://dx.doi.org/10.1016/S1474-4422(17)30375-7

Cooper-Knock J; Robins H; Niedermoser I; Wyles M; Heath PR; Higginbottom A; Walsh T; Kazoka M; Al Kheifat A; Al-Chalabi A; Basak N; Blair I; Dekker A; Hardiman O; Hide W; Iacoangeli A; Kenna K; Landers J; McLaughlin R; Mill J; Middelkoop B; Moisse M; Pardina JM; Morrison K; Newhouse S; Pulit S; Shatunov A; Shaw C; Sproviero W; Tazelaar G; van Damme P; van den Berg L; van der Spek R; Eijk K; van Es M; van Rheenen W; van Vugt J; Veldink J; Kooyman M; Glass J; Robberecht W; Gotkine M; Drory V; Kiernan M; Neto MM; Ztaz M; Couratier P; Corcia P; Silani V; Chio A; de Carvalho M; Pinto S; Redondo AG; Andersen P; Weber M; Ticozzi N; Ince PG; Hautbergue GM; McDermott CJ; Kirby J; Shaw PJ, 2017, 'Targeted genetic screen in amyotrophic lateral sclerosis reveals novel genetic variants with synergistic effect on clinical phenotype', Frontiers in Molecular Neuroscience, 10, http://dx.doi.org/10.3389/fnmol.2017.00370

Eisen A; Braak H; Del Tredici K; Lemon R; Ludolph AC; Kiernan MC, 2017, 'Cortical influences drive amyotrophic lateral sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 88, pp. 917 - 924, http://dx.doi.org/10.1136/jnnp-2017-315573

McCrary JM; Goldstein D; Boyle F; Cox K; Grimison P; Kiernan MC; Krishnan AV; Lewis CR; Webber K; Baron-Hay S; Horvath L; Park SB, 2017, 'Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey', Supportive Care in Cancer, 25, pp. 3485 - 3493, http://dx.doi.org/10.1007/s00520-017-3772-y

Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM, 2017, 'Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis', Acta neuropathologica communications, 5, pp. 76, http://dx.doi.org/10.1186/s40478-017-0480-2

Garg N; Nguyen T; Mathey E; Park S; Yiannikas C; Vucic S; Spies J; Krishan A; Pollard J; Kiernan M, 2017, 'Autoantibody targets in chronic inflammatory demyelinating polyneuropathy', JOURNAL OF THE NEUROLOGICAL SCIENCES, 381, pp. 276 - 277, http://dx.doi.org/10.1016/j.jns.2017.08.788

Kiernan M, 2017, 'Tracking neurodegeneration by TMS', JOURNAL OF THE NEUROLOGICAL SCIENCES, 381, pp. 40 - 40, http://dx.doi.org/10.1016/j.jns.2017.08.166

Timmins HC; Saw W; Cheah BC; Lin CSY; Vucic S; Ahmed RM; Kiernan MC; Park SB, 2017, 'Cardiometabolic health and risk of amyotrophic lateral sclerosis', Muscle and Nerve, 56, pp. 721 - 725, http://dx.doi.org/10.1002/mus.25547

Garg N; Howells J; Yiannikas C; Vucic S; Krishnan AV; Spies J; Bostock H; Mathey EK; Pollard JD; Park SB; Kiernan MC, 2017, 'Motor unit remodelling in multifocal motor neuropathy: The importance of axonal loss', Clinical Neurophysiology, 128, pp. 2022 - 2028, http://dx.doi.org/10.1016/j.clinph.2017.07.414

Arnold R; Pianta TJ; Pussell BA; Kirby A; O’Brien K; Sullivan K; Holyday M; Cormack C; Kiernan MC; Krishnan AV; O'Brien K, 2017, 'Randomized, controlled trial of the effect of dietary potassium restriction on nerve function in CKD', Clinical Journal of the American Society of Nephrology, 12, pp. 1569 - 1577, http://dx.doi.org/10.2215/CJN.00670117

Coffey JC; Kiernan M, 2017, 'Adipocyte-Epithelial Interactions and Crohn's Disease - An Emerging Drug Target', EBIOMEDICINE, 23, pp. 193 - 194, http://dx.doi.org/10.1016/j.ebiom.2017.08.029

De Carvalho M; Kiernan MC; Swash M, 2017, 'Fasciculation in amyotrophic lateral sclerosis: Origin and pathophysiological relevance', Journal of Neurology, Neurosurgery and Psychiatry, 88, pp. 773 - 779, http://dx.doi.org/10.1136/jnnp-2017-315574

Dale RC; Barnett MH; Kiernan MC, 2017, 'Maternal autoimmunity: Risk of neurodevelopmental and neuropsychiatric outcomes', Journal of Neurology, Neurosurgery and Psychiatry, 88, pp. 713 - 714, http://dx.doi.org/10.1136/jnnp-2017-315724

Mathey EK; Garg N; Park SB; Nguyen T; Baker S; Yuki N; Yiannikas C; Lin CS; Spies JM; Ghaoui R; Barnett MH; Vucic S; Pollard JD; Kiernan MC, 2017, 'Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies', Journal of Neuroimmunology, 309, pp. 41 - 46, http://dx.doi.org/10.1016/j.jneuroim.2017.05.002

Matamala JM; Geevasinga N; Huynh W; Dharmadasa T; Howells J; Simon NG; Menon P; Vucic S; Kiernan MC, 2017, 'Cortical function and corticomotoneuronal adaptation in monomelic amyotrophy', Clinical Neurophysiology, 128, pp. 1488 - 1495, http://dx.doi.org/10.1016/j.clinph.2017.05.005

Sillence KA; Halawani AJ; Tounsi WA; Clarke KA; Kiernan M; Madgett TE; Avent ND, 2017, 'Rapid RHD Zygosity Determination Using Digital PCR', CLINICAL CHEMISTRY, 63, pp. 1388 - 1397, http://dx.doi.org/10.1373/clinchem.2016.268698

Noto YI; Simon N; Shibuya K; Matamala JM; Dharmadasa T; Kiernan MC, 2017, 'Dynamic muscle ultrasound identifies upper motor neuron involvement in amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18, pp. 404 - 410, http://dx.doi.org/10.1080/21678421.2017.1286355

Huynh W; Kiernan MC, 2017, 'A man with MS asking about medicinal cannabis', Medicine Today, 18, pp. 56 - 59

Kandula T; Farrar MA; Kiernan MC; Krishnan AV; Goldstein D; Horvath L; Grimison P; Boyle F; Baron-Hay S; Park SB, 2017, 'Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer', Clinical Neurophysiology, 128, pp. 1166 - 1175, http://dx.doi.org/10.1016/j.clinph.2017.04.009

Menon P; Geevasinga N; van den Bos M; Yiannikas C; Kiernan MC; Vucic S, 2017, 'Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis', European Journal of Neurology, 24, pp. 816 - 824, http://dx.doi.org/10.1111/ene.13295

Garg N; Park SB; Vucic S; Yiannikas C; Spies J; Howells J; Huynh W; Matamala JM; Krishnan AV; Pollard JD; Cornblath DR; Reilly MM; Kiernan MC, 2017, 'Differentiating lower motor neuron syndromes', Journal of Neurology, Neurosurgery and Psychiatry, 88, pp. 474 - 483, http://dx.doi.org/10.1136/jnnp-2016-313526

Kiernan MC, 2017, 'Some do not like it hot', Journal of Physiology, 595, pp. 3251 - 3252, http://dx.doi.org/10.1113/JP274183

Huynh W; Kwai N; Arnold R; Krishnan AV; Lin CSY; Vucic S; Kiernan MC, 2017, 'The effect of diabetes on cortical function in stroke: Implications for poststroke plasticity', Diabetes, 66, pp. 1661 - 1670, http://dx.doi.org/10.2337/db16-0961

Shibuya K; Simon NG; Geevasinga N; Menon P; Howells J; Park SB; Huynh W; Noto YI; Vucic S; Kiernan MC, 2017, 'The evolution of motor cortical dysfunction in amyotrophic lateral sclerosis', Clinical Neurophysiology, 128, pp. 1075 - 1082, http://dx.doi.org/10.1016/j.clinph.2017.03.004

Dharmadasa T; Henderson RD; Talman PS; Al Macdonell R; Mathers S; Schultz DW; Needham M; Zoing M; Vucic S; Kiernan MC, 2017, 'Motor neurone disease: Progress and challenges', Medical Journal of Australia, 206, pp. 357 - 362, http://dx.doi.org/10.5694/MJA16.01063

Simon NG; Lagopoulos J; Paling S; Pfluger C; Park SB; Howells J; Gallagher T; Kliot M; Henderson RD; Vucic S; Kiernan MC, 2017, 'Peripheral nerve diffusion tensor imaging as a measure of disease progression in ALS', Journal of Neurology, 264, pp. 882 - 890, http://dx.doi.org/10.1007/s00415-017-8443-x

Kiernan MC, 2017, 'Transforming the management of stroke', Medical Journal of Australia, 206, pp. 342 - 343, http://dx.doi.org/10.5694/mja17.00028

Bodea LG; Evans HT; Van der Jeugd A; Ittner LM; Delerue F; Kril J; Halliday G; Hodges J; Kiernan MC; Götz J, 2017, 'Accelerated aging exacerbates a pre-existing pathology in a tau transgenic mouse model', Aging Cell, 16, pp. 377 - 386, http://dx.doi.org/10.1111/acel.12565

Matamala JM; Dharmadasa T; Kiernan MC, 2017, 'Prognostic factors in C9orf72 amyotrophic lateral sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 88, pp. 281, http://dx.doi.org/10.1136/jnnp-2016-314685

McLaughlin RL; Schijven D; Van Rheenen W; Van Eijk KR; O'Brien M; Kahn RS; Ophoff RA; Goris A; Bradley DG; Al-Chalabi A; Van Den Berg LH; Luykx JJ; Hardiman O; Veldink JH; Shatunov A; Dekker AM; Diekstra FP; Pulit SL; Van Der Spek RAA; Van Doormaal PTC; Sproviero W; Jones AR; Nicholson GA; Rowe DB; Pamphlett R; Kiernan MC; Bauer D; Kahlke T; Williams K; Eftimov F; Fogh I; Ticozzi N; Lin K; Millecamps S; Salachas F; Meininger V; Carvalho MD; Pinto S; Mora JS; Rojas-Garcyá R; Polak M; Chandran S; Colville S; Swingler R; Morrison KE; Shaw PJ; Hardy J; Orrell RW; Pittman A; Sidle K; Fratta P; Malaspina A; Petri S; Abdulla S; Drepper C; Sendtner M; Meyer T; Wiedau-Pazos M; Lomen-Hoerth C; Deerlin VMV; Trojanowski JQ; Elman L; McCluskey L; Basak N; Meitinger T; Lichtner P; Blagojevic-Radivojkov M; Andres CR; Maurel C; Bensimon G; Landwehrmeyer B; Brice A; Payan CAM; Saker-Delye S; Durr A; Wood N; Tittmann L; Lieb W; Franke A; Rietschel M; Cichon S; Nothen MM; Amouyel P; Tzourio C; Dartigues JF; Uitterlinden AG; Rivadeneira F; Estrada K; Hofman A; Curtis C; Derkooi AJV; De Visser M; Weber M; Shaw CE; Smith BN; Pansarasa O; Cereda C; Bo RD; Comi GP; D'Alfonso S, 2017, 'Genetic correlation between amyotrophic lateral sclerosis and schizophrenia', Nature Communications, 8, http://dx.doi.org/10.1038/ncomms14774

Farrar MA; Park SB; Vucic S; Carey KA; Turner BJ; Gillingwater TH; Swoboda KJ; Kiernan MC, 2017, 'Emerging therapies and challenges in spinal muscular atrophy', Annals of Neurology, 81, pp. 355 - 368, http://dx.doi.org/10.1002/ana.24864

Shibuya K; Park SB; Howells J; Huynh W; Noto YI; Shahrizaila N; Matamala JM; Vucic S; Kiernan MC, 2017, 'Laterality of motor cortical function measured by transcranial magnetic stimulation threshold tracking', Muscle and Nerve, 55, pp. 424 - 427, http://dx.doi.org/10.1002/mus.25372

Ahmed RM; Irish M; van Eersel J; Ittner A; Ke YD; Volkerling A; van der Hoven J; Tanaka K; Karl T; Kassiou M; Kril JJ; Piguet O; Götz J; Kiernan MC; Halliday GM; Hodges JR; Ittner LM, 2017, 'Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology', Neuroscience and Biobehavioral Reviews, 74, pp. 126 - 138, http://dx.doi.org/10.1016/j.neubiorev.2017.01.004

Van Den Bos MAJ; Geevasinga N; Menon P; Burke D; Kiernan MC; Vucic S, 2017, 'Physiological processes influencing motor-evoked potential duration with voluntary contraction', Journal of Neurophysiology, 117, pp. 1156 - 1162, http://dx.doi.org/10.1152/jn.00832.2016

Meininger V; Genge A; van den Berg LH; Robberecht W; Ludolph A; Chio A; Kim SH; Leigh PN; Kiernan MC; Shefner JM; Desnuelle C; Morrison KE; Petri S; Boswell D; Temple J; Mohindra R; Davies M; Bullman J; Rees P; Lavrov A, 2017, 'Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial', The Lancet Neurology, 16, pp. 208 - 216, http://dx.doi.org/10.1016/S1474-4422(16)30399-4

Matamala JM; Kiernan MC, 2017, 'Natural history and the dawning of a new era for familial ALS', Journal of Neurology, Neurosurgery and Psychiatry, 88, pp. 95 - 96, http://dx.doi.org/10.1136/jnnp-2016-313898


Back to profile page